Aflibercept Dose in Polypoidal Choroidal Vasculopathy
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Aflibercept Dose in Polypoidal Choroidal Vasculopathy
-
Narrated by:
-
By:
About this listen
Interview with Tien Y. Wong, MD, PhD, author of Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial. Hosted by Neil Bressler, MD.
Related Content:
- Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.